Production (Stage)
The Chemours Company
CC
$10.30
-$0.55-5.07%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 0.44% | -1.27% | 0.94% | -6.39% | -11.33% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.44% | -1.27% | 0.94% | -6.39% | -11.33% |
| Cost of Revenue | 5.01% | -3.11% | 0.08% | -0.08% | -7.71% |
| Gross Profit | -16.90% | 7.06% | 4.76% | -25.37% | -22.83% |
| SG&A Expenses | -11.03% | 49.62% | -19.26% | -18.72% | 9.68% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.06% | 2.28% | -1.74% | -2.62% | -5.77% |
| Operating Income | -26.67% | -50.00% | 34.55% | -34.36% | -44.95% |
| Income Before Tax | -100.00% | 113.04% | -330.77% | 118.94% | -59.54% |
| Income Tax Expenses | -75.00% | 132.08% | -400.00% | 121.05% | -42.86% |
| Earnings from Continuing Operations | -107.41% | 50.00% | -325.00% | 118.62% | -62.76% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -107.41% | 55.56% | -325.00% | 118.62% | -62.76% |
| EBIT | -26.67% | -50.00% | 34.55% | -34.36% | -44.95% |
| EBITDA | -13.61% | -25.88% | 21.51% | -26.01% | -35.69% |
| EPS Basic | -107.37% | 55.83% | -323.54% | 118.58% | -62.77% |
| Normalized Basic EPS | -55.19% | -127.63% | 45.12% | -55.79% | -62.45% |
| EPS Diluted | -108.33% | 54.04% | -325.50% | 118.24% | -62.50% |
| Normalized Diluted EPS | -54.89% | -127.63% | 46.62% | -56.00% | -62.16% |
| Average Basic Shares Outstanding | 0.59% | 0.65% | 0.72% | 0.21% | 0.03% |
| Average Diluted Shares Outstanding | -0.09% | 0.65% | -0.32% | 0.69% | -0.75% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | -14.50% | -1.19% | -1.46% | 6.23% | 1.69% |